Ivabradine: A Unique and Intriguing Medication for Treating Cardiovascular Disease.
Nawarskas JJ, Bowman BN, Anderson JR.
Cardiol Rev · review; journal article · DOI 10.1097/crd.0000000000000070 PUBLIKATIONSREGISTRET
Gå till forskningen.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för ivabradine hydrochloride. Visa hela publikationsregistret
En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publikationer i urvalet
20 träffarEffect of Ivabradine on Heart Rate and Duration of Exercise in Patients With Mild-to-Moderate Mitral Stenosis: A Randomized Comparison With Metoprolol.
Saggu DK, Narain VS, Dwivedi SK, Sethi R, Chandra S, Puri A, Saran RK.
J Cardiovasc Pharmacol · comparative study; research-article; randomized controlled trial; journal article · DOI 10.1097/fjc.0000000000000222Characterizing patients with chronic heart failure in community care after hospitalization: a potential role for ivabradine.
Elder DH, Mohan M, Cochrane L, Charles H, Lang CC.
Cardiovasc Ther · research support, non-u.s. gov't; journal article · DOI 10.1111/1755-5922.12117Effects of ivabradine on cardiac electrophysiology in dogs with age-related atrial fibrillation.
Li YD, Ji YT, Zhou XH, Jiang T, Hong YF, Li JX, Xing Q, Xiong J, Yusufuaji Y, Tang BP.
Med Sci Monit · research support, non-u.s. gov't; research-article; journal article · DOI 10.12659/msm.894320Ivabradine prolongs phase 3 of cardiac repolarization and blocks the hERG1 (KCNH2) current over a concentration-range overlapping with that required to block HCN4.
Lees-Miller JP, Guo J, Wang Y, Perissinotti LL, Noskov SY, Duff HJ.
J Mol Cell Cardiol · research support, non-u.s. gov't; journal article · DOI 10.1016/j.yjmcc.2015.05.009Effect of Combining Ivabradine and β-Blockers: Focus on the Use of Carvedilol in the SHIFT Population.
Bocchi EA, Böhm M, Borer JS, Ford I, Komajda M, Swedberg K, Tavazzi L, SHIFT investigators.
Cardiology · research support, non-u.s. gov't; multicenter study; randomized controlled trial; journal article · DOI 10.1159/000380812The Role of Ivabradine in Cardiac Rehabilitation in Patients With Recent Coronary Artery Bypass Graft.
Marazia S, Urso L, Contini M, Pano M, Zaccaria S, Lenti V, Sarullo FM, Di Mauro M.
J Cardiovasc Pharmacol Ther · randomized controlled trial; journal article · DOI 10.1177/1074248415575963hERG potassium channel blockade by the HCN channel inhibitor bradycardic agent ivabradine.
Melgari D, Brack KE, Zhang C, Zhang Y, El Harchi A, Mitcheson JS, Dempsey CE, Ng GA, Hancox JC.
J Am Heart Assoc · research support, non-u.s. gov't; research-article; journal article · DOI 10.1161/jaha.115.001813Ivabradine on aortic stiffness in patients with heart failure.
Nar G, Inci S, Aksan G, Demirelli S, Soylu K, Yuksel S, Gulel O, Icli A.
J Investig Med · clinical trial; multicenter study; journal article · DOI 10.1097/jim.0000000000000159[The efficacy of ivabradine in chronic heart failure (review)].
Isakadze A, Makharadze T, Gvishiani M.
Georgian Med News · review; journal articleTwenty-four-hour heart rate lowering with ivabradine in chronic heart failure: insights from the SHIFT Holter substudy.
Böhm M, Borer JS, Camm J, Ford I, Lloyd SM, Komajda M, Tavazzi L, Talajic M, Lainscak M, Reil JC, Ukena C, Swedberg K.
Eur J Heart Fail · journal article · DOI 10.1002/ejhf.258A case of atrial tachycardia treated with ivabradine as bridge to ablation.
Meles E, Carbone C, Maggiolini S, Moretti P, DE Carlini CC, Gentile G, Gnecchi-Ruscone T.
J Cardiovasc Electrophysiol · journal article; case reports · DOI 10.1111/jce.12636Effects of ivabradine therapy on heart failure biomarkers.
Ordu S, Yildiz BS, Alihanoglu YI, Ozsoy A, Tosun M, Evrengul H, Kaftan HA, Ozhan H.
Cardiol J · randomized controlled trial; journal article · DOI 10.5603/cj.a2015.0012Addition of ivabradine to β-blocker improves exercise capacity in systolic heart failure patients in a prospective, open-label study.
Bagriy AE, Schukina EV, Samoilova OV, Pricolota OA, Malovichko SI, Pricolota AV, Bagriy EA.
Adv Ther · research support, non-u.s. gov't; journal article · DOI 10.1007/s12325-015-0185-5Ivabradine in combination with Beta-blockers in patients with chronic stable angina after percutaneous coronary intervention.
Werdan K, Ebelt H, Nuding S, Höpfner F, Stöckl G, Müller-Werdan U.
Adv Ther · research support, non-u.s. gov't; research-article; multicenter study; journal article · DOI 10.1007/s12325-015-0182-8Torsades de pointes induced by the concomitant use of ivabradine and azithromycin: an unexpected dangerous interaction.
Cocco G, Jerie P.
Cardiovasc Toxicol · journal article; case reports · DOI 10.1007/s12012-014-9274-yCombined actions of ivabradine and ranolazine reduce ventricular rate during atrial fibrillation.
Verrier RL, Silva AF, Bonatti R, Batatinha JA, Nearing BD, Liu G, Rajamani S, Zeng D, Belardinelli L.
J Cardiovasc Electrophysiol · research support, non-u.s. gov't; journal article · DOI 10.1111/jce.12569Ivabradine improves left ventricular function during chronic hypertension in conscious pigs.
Rienzo M, Melka J, Bizé A, Sambin L, Jozwiak M, Su JB, Hittinger L, Berdeaux A, Ghaleh B.
Hypertension · research support, non-u.s. gov't; journal article · DOI 10.1161/hypertensionaha.114.04323Ivabradine during cardiogenic shock: a clinical case and review of the literature.
Bonadei I, Sciatti E, Vizzardi E, D'Aloia A, Metra M.
Heart Lung · review; journal article; case reports · DOI 10.1016/j.hrtlng.2014.08.003I(f) current inhibitor ivabradine in patients with idiopathic dilated cardiomyopathy: Impact on the exercise tolerance and quality of life.
Abdel-Salam Z, Rayan M, Saleh A, Abdel-Barr MG, Hussain M, Nammas W.
Cardiol J · research support, non-u.s. gov't; randomized controlled trial; journal article · DOI 10.5603/cj.a2014.0057